ES2003863A4 - Procedimiento para producir una preparacion de liberacion controlada de metoprolol y uso de dicha preparacion. - Google Patents

Procedimiento para producir una preparacion de liberacion controlada de metoprolol y uso de dicha preparacion.

Info

Publication number
ES2003863A4
ES2003863A4 ES86850330T ES86850330T ES2003863A4 ES 2003863 A4 ES2003863 A4 ES 2003863A4 ES 86850330 T ES86850330 T ES 86850330T ES 86850330 T ES86850330 T ES 86850330T ES 2003863 A4 ES2003863 A4 ES 2003863A4
Authority
ES
Spain
Prior art keywords
preparation
controlled release
metoprolol
procedure
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES86850330T
Other languages
English (en)
Other versions
ES2003863B3 (es
Inventor
Ulf Erik Jonsson
John Anders Sandberg
John Albert Sjogren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20361706&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2003863(A4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hassle AB filed Critical Hassle AB
Publication of ES2003863A4 publication Critical patent/ES2003863A4/es
Application granted granted Critical
Publication of ES2003863B3 publication Critical patent/ES2003863B3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PREPARACION DE LIBERACION CONTROLADA CONTIENE UN NUMERO DE GRANULOS DE SAL DE METOPROLOL COMO PRINCIPAL COMPONENTE SOLUBLE, UN METODO PARA LA PRODUCCION DEL MISMO Y SU USO EN EL TRATAMIENTO DE TRASTORNOS CARDIOVASCULARES.
ES86850330T 1985-10-11 1986-10-02 Nueva preparacion farmaceutica con liberacion controlada de metoprolol, metodo para su fabricacion y uso de la nueva preparacion. Expired - Lifetime ES2003863B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8504721A SE455836B (sv) 1985-10-11 1985-10-11 Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning

Publications (2)

Publication Number Publication Date
ES2003863A4 true ES2003863A4 (es) 1988-12-01
ES2003863B3 ES2003863B3 (es) 1992-01-16

Family

ID=20361706

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86850330T Expired - Lifetime ES2003863B3 (es) 1985-10-11 1986-10-02 Nueva preparacion farmaceutica con liberacion controlada de metoprolol, metodo para su fabricacion y uso de la nueva preparacion.

Country Status (33)

Country Link
US (1) US4957745A (es)
EP (1) EP0220143B1 (es)
JP (1) JPH0759506B2 (es)
KR (1) KR940000100B1 (es)
CN (1) CN1023293C (es)
AT (1) ATE65391T1 (es)
AU (1) AU588630B2 (es)
CY (1) CY1616A (es)
DD (1) DD259789A5 (es)
DE (2) DE220143T1 (es)
DK (1) DK165939C (es)
DZ (1) DZ994A1 (es)
ES (1) ES2003863B3 (es)
FI (1) FI88579C (es)
GB (1) GB2181348B (es)
GR (2) GR890300059T1 (es)
HK (1) HK101791A (es)
HU (1) HU197839B (es)
IE (1) IE59053B1 (es)
IS (1) IS1529B (es)
LT (2) LT3951B (es)
LV (3) LV10913B (es)
NO (1) NO172276C (es)
NZ (1) NZ217696A (es)
PH (1) PH22277A (es)
PL (1) PL261802A1 (es)
PT (1) PT83509B (es)
RU (1) RU2072840C1 (es)
SE (1) SE455836B (es)
SG (1) SG95291G (es)
SU (1) SU1760969A3 (es)
UA (2) UA26211A (es)
ZA (1) ZA869860B (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
DE69107461T2 (de) * 1990-08-07 1995-06-22 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
ATE141049T1 (de) * 1991-03-18 1996-08-15 Sepracor Inc Zubereitung und verfahren enthaltend optisch reines s-metoprolol
ES2073301T3 (es) * 1991-05-20 1995-08-01 Marion Laboratories Inc Composicion multi-capa de liberacion controlada.
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
SE9702338D0 (sv) * 1997-06-18 1997-06-18 Astra Ab An analytical method and industrial process including the same
SE9802537D0 (sv) * 1998-07-13 1998-07-13 Astra Ab Method for controlling a coating process
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
DE19842753A1 (de) * 1998-09-18 2000-03-23 Bayer Ag Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
AU6283299A (en) * 1998-10-01 2000-04-17 Elan Pharma International Limited Controlled release nanoparticulate compositions
US8293277B2 (en) 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US8236352B2 (en) 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
DE19848651C1 (de) * 1998-10-22 2000-01-27 Porsche Ag Tülle für ein Kabelbündel
AU764469B2 (en) * 1999-01-29 2003-08-21 Disphar International B.V. Pharmaceutical compositions
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
US7198795B2 (en) 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
GB0025208D0 (en) 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US6610326B2 (en) * 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
US20040105886A1 (en) * 2001-02-16 2004-06-03 Chih-Ming Chen Divalproex sodium tablets
SE0100824D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method III to obtain microparticles
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
RU2190397C1 (ru) * 2001-10-25 2002-10-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, содержащая кардиоселективный бета-адреноблокатор, и способ ее получения
SK9132003A3 (en) * 2001-12-19 2004-02-03 Astrazeneca Ab A film coating composition, a coating film, pharmaceutical formulation comprising same and a process for its production
DK1471887T3 (da) 2002-02-04 2010-06-07 Elan Pharma Int Ltd Nanopartikelkompositioner der har lysozym som overfladestabiliseringsmiddel
CA2481091A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7217300B2 (en) 2003-06-27 2007-05-15 Delphi Technologies, Inc. Method and apparatus for gasketing a fuel cell
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050032879A1 (en) * 2003-08-07 2005-02-10 Temple Okarter Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
WO2005077331A1 (en) * 2004-02-11 2005-08-25 Athpharma Limited Chronotherapeutic compositions and methods of their use
US20060105044A1 (en) 2004-05-20 2006-05-18 Singh Bramah N Sustained release formulations of sotalol
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
AU2005299490C1 (en) 2004-10-21 2012-01-19 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
EP1898886B1 (en) * 2005-07-01 2019-09-04 Rubicon Research Pvt Ltd. Novel sustained release dosage form
US20070009589A1 (en) * 2005-07-07 2007-01-11 Kandarapu Raghupathi Extended release compositions
WO2007010501A2 (en) * 2005-07-22 2007-01-25 Ranbaxy Laboratories Limited A pharmaceutical composition comprising a combination of beta blocker and an ace inhibitor
US20070053983A1 (en) * 2005-09-06 2007-03-08 Girish Jain Extended release compositions of metoprolol succinate
US20070092573A1 (en) * 2005-10-24 2007-04-26 Laxminarayan Joshi Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist
DE102005060393A1 (de) 2005-12-16 2007-06-21 Add Advanced Drug Delivery Technologies Ltd. Orales Präparat mit kontrollierter Freisetzung
US8691272B2 (en) * 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
US20090068260A1 (en) * 2006-02-24 2009-03-12 Tomer Gold Beta-1-selective adrenoceptor blocking agent compositions and methods for their preparation
US20070202172A1 (en) * 2006-02-24 2007-08-30 Tomer Gold Metoprolol succinate E.R. tablets and methods for their preparation
BRPI0714586A2 (pt) * 2006-07-28 2013-05-07 Farmaprojects S A formulaÇço farmacÊutica de liberaÇço prolongada de metropolol e processo para a sua preparaÇço
US20080107726A1 (en) * 2006-11-01 2008-05-08 Pramod Kharwade Compositions comprising beta-adrenergic receptor antagonists and diuretics
US20080187579A1 (en) * 2007-02-01 2008-08-07 Pavan Bhat Extended-release dosage form
US20110014295A1 (en) * 2007-02-23 2011-01-20 Glatt Air Techniques, Inc. Method of determining the weight of the coating to be applied to form a controlled release dosage form
EP2255791B1 (en) * 2009-04-03 2011-11-16 Zaklady Farmaceutyczne Polpharma SA Extended release pharmaceutical composition comprising metoprolol succinate
KR101765357B1 (ko) 2009-12-02 2017-08-04 아데어 파마수티컬스 에스.알.엘. 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
CN102670539A (zh) * 2011-03-14 2012-09-19 北京天衡药物研究院 琥珀酸美托洛尔渗透泵控释片
BR112015018895A2 (pt) 2013-02-13 2017-07-18 Evonik Roehm Gmbh composição farmacêutica multiparticulada compreendendo uma multiplicidade de dois tipos de pelotas
EP2968164A4 (en) * 2013-03-15 2016-10-26 David Barnes COMPOSITIONS AND METHODS OF ADMINISTRATION TO DYSPHAGIA SUBJECTS

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH532038A (de) * 1970-05-25 1972-12-31 Ciba Geigy Ag Verfahren zur Herstellung von neuen Cycloheptenderivaten
US3951821A (en) * 1972-07-14 1976-04-20 The Dow Chemical Company Disintegrating agent for tablets
US4036227A (en) 1973-04-25 1977-07-19 Alza Corporation Osmotic releasing device having a plurality of release rate patterns
US4123382A (en) * 1973-05-25 1978-10-31 Merck & Co., Inc. Method of microencapsulation
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4291016A (en) * 1976-07-27 1981-09-22 Sandoz Ltd. Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate
GB1542414A (en) * 1976-08-19 1979-03-21 Standard Telephones Cables Ltd Arrangements for the controlled release of biologically active materials
DE2642032C2 (de) * 1976-09-18 1987-04-30 Rupprecht, Herbert, Prof. Dr., 8400 Regensburg Verfahren zur Inkorporierung von Wirkstoffen in siliciumdioxidhaltige Trägermaterialien und eine siliciumdioxidhaltige Zubereitung
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
SE426548B (sv) * 1978-12-05 1983-01-31 Haessle Ab Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4309404A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
CH655658B (es) * 1980-09-18 1986-05-15
US4439195A (en) * 1980-10-14 1984-03-27 Alza Corporation Theophylline therapy
US4326525A (en) * 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
GB2098867B (en) * 1981-05-21 1984-10-24 Wyeth John & Brother Ltd Sustained release pharmaceutical composition
US4484921A (en) * 1982-02-01 1984-11-27 Alza Corporation Theophylline therapy utilizing osmotic delivery
US4649043A (en) * 1982-03-22 1987-03-10 Alza Corporation Drug delivery system for delivering a plurality of tiny pills in the gastrointestinal tract
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4642233A (en) * 1982-03-22 1987-02-10 Alza Corporation Gastrointestinal drug delivery system comprising a hydrogel reservoir containing a plurality of tiny pills
US4434153A (en) * 1982-03-22 1984-02-28 Alza Corporation Drug delivery system comprising a reservoir containing a plurality of tiny pills
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
AU1873783A (en) * 1982-10-08 1984-04-12 Verex Laboratories Inc. Constant release formulation
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
EP0147437A4 (en) * 1983-05-31 1987-03-05 Choong-Gook Jang DRY COMPOSITIONS WITH DIRECT COMPRESSION FOR DOSAGE FORMS WITH CONTROLLED ADMINISTRATION.
GB2146531B (en) * 1983-09-15 1987-04-29 Stc Plc Controlled release system
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
WO1985003436A1 (en) * 1984-02-10 1985-08-15 A/S Alfred Benzon Diffusion coated multiple-units dosage form
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
GB2159715B (en) * 1984-06-04 1988-05-05 Sterwin Ag Pharmaceutical composition in sustained release unit dose form and process for its preparation
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.

Also Published As

Publication number Publication date
AU6317186A (en) 1987-04-16
EP0220143A1 (en) 1987-04-29
GR3002571T3 (en) 1993-01-25
US4957745A (en) 1990-09-18
DE220143T1 (de) 1989-01-26
SE8504721D0 (sv) 1985-10-11
NZ217696A (en) 1989-05-29
PT83509B (pt) 1989-05-31
HUT42324A (en) 1987-07-28
RU2072840C1 (ru) 1997-02-10
LTIP1680A (en) 1995-07-25
HK101791A (en) 1991-12-20
GB2181348B (en) 1989-09-13
UA26211A (uk) 1999-07-19
EP0220143B1 (en) 1991-07-24
GR890300059T1 (en) 1989-06-22
NO863997D0 (no) 1986-10-07
GB2181348A (en) 1987-04-23
KR870003778A (ko) 1987-05-04
UA39162C2 (uk) 2001-06-15
CN1023293C (zh) 1993-12-29
IS1529B (is) 1993-02-23
DE3680450D1 (de) 1991-08-29
NO863997L (no) 1987-04-13
SE8504721L (sv) 1987-04-12
FI864108L (fi) 1987-04-12
LV5751B4 (lv) 1997-06-20
PL261802A1 (en) 1987-08-10
JPH0759506B2 (ja) 1995-06-28
SU1760969A3 (ru) 1992-09-07
KR940000100B1 (ko) 1994-01-05
PT83509A (en) 1986-11-01
JPS6296420A (ja) 1987-05-02
LV5751A4 (lv) 1996-12-20
PH22277A (en) 1988-07-14
IE59053B1 (en) 1993-12-15
DK478186A (da) 1987-04-12
AU588630B2 (en) 1989-09-21
FI88579B (fi) 1993-02-26
CY1616A (en) 1992-07-10
NO172276C (no) 1993-06-30
IS3151A7 (is) 1987-04-12
ES2003863B3 (es) 1992-01-16
IE862492L (en) 1987-04-11
DK478186D0 (da) 1986-10-07
LT3951B (en) 1996-05-27
HU197839B (en) 1989-06-28
ATE65391T1 (de) 1991-08-15
LV10913B (en) 1996-08-20
ZA869860B (en) 1987-05-27
CN86106588A (zh) 1987-04-08
GB8623048D0 (en) 1986-10-29
LV10913A (lv) 1995-12-20
SG95291G (en) 1992-01-17
LTIP1679A (en) 1995-07-25
DK165939B (da) 1993-02-15
FI864108A0 (fi) 1986-10-10
DZ994A1 (fr) 2004-09-13
LV10914A (lv) 1995-12-20
DD259789A5 (de) 1988-09-07
DK165939C (da) 1993-07-05
FI88579C (fi) 1993-06-10
NO172276B (no) 1993-03-22
SE455836B (sv) 1988-08-15

Similar Documents

Publication Publication Date Title
ES2003863B3 (es) Nueva preparacion farmaceutica con liberacion controlada de metoprolol, metodo para su fabricacion y uso de la nueva preparacion.
ATA448678A (de) Verfahren zur herstellung des neuen tetrahydroisoxazol(5a,4-c)pyridin-3-ols und von dessen salzen
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
DE68900371D1 (de) Textile struktur zur herstellung von schichtstoffen und schichtformteile, die diese struktur enthalten.
AR218853A1 (es) Proceso y aparato para la produccion de agua de beber natural,biologicamente segura
ES2042742T3 (es) Procedimiento para preparar furanonas antiinflamatorias.
ATA78476A (de) Enossales implantat zur befestigung von festsitzendem zahnersatz, vorrichtung zum passgenauen herstellen von ausfraesungen dafuer sowie versenkinstrument zum versenken des implantats
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
IT8248666A0 (it) Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri eloro impiego farmaceutico
ES444925A1 (es) Procedimiento para preparar un triazolobenzocicloalquiltia- diazina.
IT7826282A0 (it) Esuronil esosaminoglicano solfato naturale, procedimento per la sua preparazione e impieghi terapeutici relativi.
IT8621836A0 (it) Nuovi derivati del catecolo, procedimento per la loro preparazione e composizione terapeutiche che li contengono.
ES453883A1 (es) Un procedimiento para la preparacion de derivados sustitui- dos de 2h-piran-2, 6(3h)-diona.
ES520843A0 (es) Procedimiento para la obtencion de nuevos derivados del indolizino (8,7-b 7-indol.
IL48848A0 (en) New n-sulphenylated phenylformamidines,their production and their use as pesticides
JPS5234937A (en) Coccidicides
JPS5217972A (en) Method of marking a neckchain neckchain
JPS51146948A (en) Method of manufacturing natural leather insole